Evidence map›Paper›PMID 35045249›Full record

ArticleACS applied bio materials2022

Nanoarchitectonics of a Microsphere-Based Scaffold for Modeling Neurodevelopment and Neurological Disease.

Eric S Sandhurst, Sharad V Jaswandkar, Krishna Kundu, Dinesh R Katti, Kalpana S Katti, Hongli Sun, Daniel Engebretson, Kevin R Francis

Open access · hybridAbstract read
In one paragraph

Article in ACS applied bio materials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. [Establishment and biological effect evaluation of prevascularized porous β-tricalcium phosphate tissue engineered bone].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2022
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Eric S SandhurstDepartment of Biomedical Engineering, University of South Dakota, Sioux Falls, South Dakota 57107, United States.
Sharad V JaswandkarCivil, Construction and Environmental Engineering Department, North Dakota State University, Fargo, North Dakota 58108, United States.ORCID 0000-0003-3959-0071
Krishna KunduCivil, Construction and Environmental Engineering Department, North Dakota State University, Fargo, North Dakota 58108, United States.ORCID 0000-0002-4122-7784
Dinesh R KattiCivil, Construction and Environmental Engineering Department, North Dakota State University, Fargo, North Dakota 58108, United States.ORCID 0000-0001-9866-2683
Kalpana S KattiCivil, Construction and Environmental Engineering Department, North Dakota State University, Fargo, North Dakota 58108, United States.ORCID 0000-0002-1404-4018
Hongli SunDepartment of Biomedical Engineering, University of South Dakota, Sioux Falls, South Dakota 57107, United States.ORCID 0000-0001-8398-3011
Daniel EngebretsonDepartment of Biomedical Engineering, University of South Dakota, Sioux Falls, South Dakota 57107, United States.ORCID 0000-0002-7240-734X
Kevin R FrancisDepartment of Biomedical Engineering, University of South Dakota, Sioux Falls, South Dakota 57107, United States.ORCID 0000-0002-3636-7264
North Dakota State University · USUniversity of South Dakota · US

Funding

Yeast 2 HybridP20GM103620 · NIGMS · SANFORD RESEARCH/USD · PI ROUX, KYLE J · 2013 to 2023
$24.2M
The Impact of PD-1 Inhibition on Immune-Response to ChemoradiotherapyP20GM103548 · NIGMS · SANFORD RESEARCH/USD · PI EGLAND, KRISTI A · 2012 to 2020
$20.8M
NIGMS NIH HHS P20 GM103548NIGMS NIH HHS P20 GM103620
6 · The paper itself

Abstract

Three-dimensional cellular constructs derived from pluripotent stem cells allow the

Indexed as

Induced Pluripotent Stem CellsNervous System DiseasesNeural Stem CellsEndothelial CellsHumansMicrospheresinduced pluripotentiPSCmicrospherenanoarchitectonicNSCscaffoldthree-dimensional

Identifiers

PMID35045249
PMCPMC8865216
OpenAlexW4206690336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.